Materials and Methods

Materials
Acetovanillone, t-butyl bromoacetate, nitric acid, 11-azido-3,6,9-trioxaundecan-1-amine, magnesium sulfate, hydrazine monohydrate, manganese dioxide, molecular sieves, HATU and human recombinant insulin were purchased from Sigma Aldrich. DMSO and DMF were stored in molecular sieves containing glass vials and used as stated. DMF, DMSO, DCM, acetonitrile, methanol, ethanol, ethyl 
HPLC and Spectrometry
UV-Vis analysis was performed using a USB-2000 fiber optic spectrometer (Ocean Optics, Inc.) with a DT-Mini-B lamp source. HPLC analysis was performed using modular Hewlett Packard Agilent 1050 and 1260 series instruments with attached vacuum degasser, auto sampler and diode array detector. C18 Hypersil (5 µm, 250 × 4.6 mm, Varian) columns were used as stated in the method. HPLC-MS was performed using a modular Agilent 1100 series with DAD coupled with a Q-Trap mass spectrometer (ABI) in a positive ion mode. For HPLC-MS analysis C18 Hypersil (5 µm, 250 × 4.6 mm, Varian) column was used. ESI-MS of small molecules was performed using the Q-Trap mass spectrometer (ABI) instrument in infusion mode. ESI-MS for insulin containing molecules was performed using a 3200 Q-Trap mass spectrometer. Compounds 1, 2 were synthesized in two steps as previously described(1).
Compounds 3, 4 were synthesized as previously described(2) 
ESI-MS analysis
In-vivo testing of insulin PAD
Light source
The light source was constructed from a Nichia NCSU033B LED, with a 365nm peak irradiation. This was driven by a 6.5 V power source using a current limiting power resistor. The light source holds the LED ~0.32cm from the skin surface, and the measured absolute irradiance at the skin was 0.71 W/cm 2 . The absolute irradiance of the light source was determined using a calibrated USB2000 spectrophotometer (Ocean Optics) and a CC-3-UV-S cosine corrector via an optic fiber. The Spectrasuite software was used to analyze absolute irradiance in the range of 350-400 nm that brackets the LED output.
Animals
Spague Dawley male rats (250-300 grams) were obtained from Harlan Laboratories 
Intradermal injection of PAD material
Rats were anesthetized with isoflurane gas using a precision vaporizer. The upper backs of rats were shaved prior to injection of the PAD materials. Injections of ~80 ul of PAD material were made using a ½ cc syringe and a 27 gauge needle. Due to limitations of the volume of material that can be injected into the dermal layer of skin at one time, 2 injections (40ul each) of PAD materials were made side by side. The compact LED light source was anchored to the skin over the injection sites by 2 small dots of superglue.
Rats' body temperature and hydration was maintained though out the experiment.
Insulin analysis by ELISA
Blood samples were collected in Microvette 100 µL Li-HEP tubes (Sarstedt) from the tail-vein using a glass capillary. After collecting all time points from an experiment, the samples were centrifuged at 5000 rpm for 2 minutes. The supernatant was removed at stored at -20°C until the ELISA analysis was performed. The ultrasensitive human insulin ELISA kit (Alpco, Salem, NH) was used according to the manufacturer's instructions.
Glucose measurements
Glucose measurements were made using One Touch II Lifescan glucometer and strips (Johnson & Johnson, Milpitas, CA) using plasma from blood samples obtained from the tail vein.
Statistical Analysis
The two sample unequal variance t-test was used to calculate p-value between the experimental and control groups (Excel).
